化工企业Versum Materials董事会支持医药公司默克64亿美元收购提案赢,并将终止与Entegris的协议。默克承诺负担Versum Materials5.7亿美元的净负债。
Merck successfully managed to break up a deal between two US chemicals companies on Monday following a six-week hostile campaign, winning support from the board of Versum Materials for its $6.4bn proposal to buy the group.
默克 $默沙东(MRK)$ 在经过6周的敌意收购后,于周一成功地打破了两家美国化工企业之间的交易,赢得了 Versum Materials 董事会64亿美元收购该集团的支持。
Versum, which had rejected Merck’s prior overtures, said it had agreed a new $53 per share offer from the German healthcare and life sciences group was superior to the all-stock deal it had struck with rival Entegris in January. Merck will also assume Versum’s roughly $570m of net debt as part of the transaction.
Versum 拒绝了默克(Merck)之前的提议。该公司表示,已同意德国医疗和生命科学集团提出的每股53美元的新报价,高于1月份与竞争对手 Entegris 达成的全股票交易。默克(Merck)还将承担 Versum 约5.7亿美元的净债务,作为交易的一部分。
Merck had previously offered to pay $48 per share for Versum, triggering a rally in the US chipmaker supplier’s share price. Versum said that following Merck’s revised offer it agreed to terminate its agreement with Entegris, which offered to buy the Arizona-based group for just over $4bn.
默克( Merck )此前曾提出以每股48美元收购 Versum ,引发这家美国芯片制造商的股价上涨。Versum 表示,在默克(Merck)提出修订后的报价后,该公司同意终止与 Entegris 的协议。 Entegris 提出以略高于40亿美元的价格收购这家总部位于亚利桑那州的集团。
Entegris has up until April 11 to make a counter offer or can agree to end the deal and accept a $140m termination fee from Versum.
Entegris 直到4月11日才提出反要约,或同意终止交易,并接受 Versum 支付的1.4亿美元终止费。
精彩评论